Preprint
Article

This version is not peer-reviewed.

Metabolomics Patterns in Subjects with Multimorbidity: Implications for Free Carnitine and Medium-Chain Acylcarnitines as Predictors of Individual Fitness Adaptation

Submitted:

07 May 2026

Posted:

08 May 2026

You are already at the latest version

Abstract
(1) Background: The MultiPill-Exercise study was an exercise-based lifestyle intervention program for subjects with more than one lifestyle-related disease. Metabolomics-based approaches are an emerging tool in sports medicine, both in basic science and in clinical contexts. In this explorative, hypothesis-generating study, we aimed at defining metabolite patterns in subjects with multimorbidity and to test the predictive value of metabolite patterns for fitness adaptation. (2) Methods: A targeted tandem mass spectrometry (MS) approach on dried spots of capillary blood was employed, analyzing n = 86 subjects. (3) Results: In response to an acute bout of exhaustive exercise, aromatic amino acids (AA) tyrosine (Tyr) and phenylalanine (Phe), total carnitine (Cx) and short- as well as medium-chain acylcarnitines (SCA and MCA) were upregulated. Furthermore, concentrations of most metabolites were higher in males. Multiple regression defined free carnitine (C0), MCA and MCADelta, i.e. changes in concentrations during acute exercise, as important predictors of intervention-associated fitness adaptation after six months, explaining 24.8% and 24.4% of absolute and relative power gains associated with a respiratory quotient (RQ) of 1, a submaximal fitness parameter. (4) Conclusions: Our data suggest utility of metabolomics data in subjects with multimorbidity, both in the context of basic research and clinical applications.
Keywords: 
;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated